Tower Research Capital LLC (TRC) - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 93 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$26,135
+57.8%
2,714
+47.5%
0.00%0.0%
Q2 2023$16,560
+206900.0%
1,840
+77.9%
0.00%
Q1 2023$8
-46.7%
1,034
-54.9%
0.00%
-100.0%
Q4 2022$15
-99.9%
2,292
+17.3%
0.00%
Q3 2022$29,000
+38.1%
1,954
-7.8%
0.00%
Q2 2022$21,000
-34.4%
2,119
-3.2%
0.00%
Q1 2022$32,000
+255.6%
2,188
+218.5%
0.00%
Q4 2021$9,000
-40.0%
687
-20.6%
0.00%
Q3 2021$15,000
-90.5%
865
-86.9%
0.00%
-100.0%
Q2 2021$158,000
+66.3%
6,601
+79.2%
0.00%
+100.0%
Q1 2021$95,000
+35.7%
3,684
+0.3%
0.00%0.0%
Q4 2020$70,000
-62.8%
3,674
-75.5%
0.00%0.0%
Q3 2020$188,000
+13.9%
14,971
+9.6%
0.00%
-71.4%
Q2 2020$165,000
+266.7%
13,659
+252.3%
0.01%
+133.3%
Q3 2019$45,000
+1025.0%
3,877
+1919.3%
0.00%
Q2 2019$4,000
+300.0%
192
+464.7%
0.00%
Q1 2019$1,000
-75.0%
34
-79.0%
0.00%
Q4 2018$4,000
-89.7%
162
-90.7%
0.00%
-100.0%
Q3 2018$39,000
+1200.0%
1,742
+431.1%
0.00%
Q2 2018$3,000
-75.0%
328
-74.4%
0.00%
-100.0%
Q1 2018$12,000
+50.0%
1,281
+52.5%
0.00%0.0%
Q4 2017$8,000
+14.3%
840
-7.2%
0.00%0.0%
Q2 2017$7,000
+16.7%
905
+28.4%
0.00%0.0%
Q1 2017$6,000
+200.0%
705
+168.1%
0.00%
Q4 2016$2,0002630.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,719,576$25,679,00012.37%
Vivo Capital, LLC 1,618,296$30,731,0001.37%
Opaleye Management Inc. 470,203$8,929,0001.17%
INTERWEST VENTURE MANAGEMENT CO 388,766$7,383,0000.92%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,433$3,369,0000.92%
Ikarian Capital, LLC 1,063,961$20,204,0000.89%
Ghost Tree Capital, LLC 200,000$3,798,0000.85%
Logos Global Management LP 490,000$9,305,0000.80%
Eventide Asset Management 1,680,000$31,903,0000.49%
Affinity Asset Advisors, LLC 45,000$855,0000.45%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders